# To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers

> **NCT03004404** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 84 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Placebo
- **DRUG:** BI 730357
- **DRUG:** BI 730357

## Key facts

- **NCT ID:** NCT03004404
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-12
- **Primary completion:** 2017-08-15
- **Final completion:** 2017-08-15
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03004404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03004404, "To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03004404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*